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ABSTRACT  
In the present work, double walled microspheres of Tamoxifen (antiestrogenic drug) using Sodium alginate, Hydroxy propyl methyl cellulose 
(HPMC) K100,Guar gum, Xanthun gum were formulated to deliver Tamoxifen (TMX) through  oral route to treat breast cancer patients. Details 
regarding the preparation and evaluation of the formulations have been discussed in results. From the study following conclusions could be 
drawn. The results of this investigation indicate that Ion gelation method can be successfully employed to fabricate TMX microspheres. FT-IR 
spectra of the physical mixture revealed that the drug is compatible with the polymers and copolymer used. Microspheres containing sodium 
alginate along with HPMC in 1:1 ratio had a least size range of 610µm. Increase in the polymer concentration led to increase in % Yield, % Drug 
entrapment efficiency, Particle size. The  invitro drug release decreased with increase in the polymer and copolymer concentration. Among all 
formulations F7 shows Maximum drug release in 12 th hr  when compared with other formulations. Analysis of drug release mechanism showed that the 
drug release from the formulations followed the Non fickian diffusion mechanism and follows zero order kinectics. 
Based on the results of evaluation tests formulation coded F7 was concluded as best formulation. 
Keywords : Tamoxifen, sodium alginate, HPMC, Microspheres, Diffusion, Copolymers,  Entrapment efficiency.  
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1. INTRODUCTION 
For many decades, medication of an acute disease or a 
chronic illness has been  accomplished by delivering drugs 
to the patients via various pharmaceutical dosage  forms  
like  tablets,  capsules,  pills,  creams,  ointments,  liquids,  
aerosol, injectables  and  suppositories  as carriers. To 
achieve  and then to maintain the concentration of  drug 
administered within the therapeutically effective range 
needed for medication, it is  often necessary to take this type 
of drug delivery systems several times a day. This results in 
a fluctuated drug level and consequently undesirable toxicity 
and poor efficiency. This factor as well as other factors such 
as repetitive dosing and unpredictable absorption leads to 
the concept of controlled drug delivery systems.1,2 
The objectives in designing a controlled release system are 
to deliver the drug at a rate necessary to achieve and 
maintain a constant drug blood level. This rate should be 
analogous to that achieved by continuous intravenous 
infusion where a drug is provided to the patient at a rate just 
equal to its rate of elimination. This implies that the rate of 
delivery must be independent of the amount of drug 
remaining in the dosage form and constant over time. That is 
release from the dosage form should follow zero-order 
kinetics.3 
Micro particles have been widely accepted as a means to 
achieve oral and parenteral controlled release. The 
microsphere requires a polymeric substance as a coat 
material or carrier. A number of different substances 
biodegradable as well as non- biodegradable have been 
investigated for the preparation of micro particles4. It not 
only reduces the dose of the drug, reaching to the effective 
biological sites rapidly but also results in reduced toxicity of 
the targeting. But in the past few years, pharmacists have 
been focused their research in colloidal drug delivery 
system/colloidal carriers, like liposomes, microspheres and 
nanoparticles as a targeting carriers, which has given 
selective targeting. 
Present microsphere delivery system technology consisting 
of a single drug dispersed within a polymer matrix has 
several drawbacks. One is the problem of the so-called 
“burst effect”. By exploiting the phenomenon of phase 
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separation between two immiscible polymers dissolved in a 
mutual solvent, a double-walled microsphere could be 
manufactured with the second polymer coating the 
polymer/drug matrix. This one-step process would give a 
consistent coating of even very small microspheres not 
achievable via normal, two-step coating processes and 
would help to smooth out the release curve by lessening the 
“burst effect”5. Along with solving the problem of the “burst 
effect”, this concept of double-walled microspheres could be 
used to achieve constant release of the drug over long 
periods of time. So far, this has only been achieved with a 
limited number of geometric configurations. Since every 
polymer has its own characteristic release rate, the release 
could be kept much more constant by changing the polymer 
type and/or properties. By combining these layers so that 
the release rate of one layer would complement the slowing 
of release due to decreased surface area or increased 
diffusion distances. 
Cancer is one of the major health problems in India; Breast 
cancer is most fatal disease for women worldwide. 
Tamoxifen (TMX) is a synthetic drug used for breast cancer 
treatment. TMX acts as antiestrogen agent via active 
metabolite hydroxytamoxifen. TMX used to treat different 
stages of breast cancer; in very high doses it may develop 
some adverse conditions like endometrial cancer and tumor 
progression.   Encapsulation materials were used to 
minimize the disadvantageous effects and deliver the TMX 
drug to the tumor site. Nanoparticles, alginate 
microsphers/microparticles, polymeric micelles and 
hydrogels are examples for TMX carriers6. 
2. MATERIALS AND METHODOLOGY 
2.1 Materials 
Tamoxifen drug was gifted sample from Chandra labs, 
Hyderabad. Polymers like HPMC, Sodium alginate, Guar gum 
and xanthan gum were purchased from S.D. fine chemicals 
ltd, Mumbai. Other ingredients, solvents and reagents were 
analytical grade only.                           
2.2 Methodology 
2.2.1 Estimation of Tamoxifen7 
Standard Stock solution: 100 mg of Tamoxifen was 
dissolved in small quantity of Methanol and make up to 100 
ml of 0.1N HCL to give a concentration of (1000 μg/ml) 
Scanning: From the stock solution 100μg/ml was prepared 
and UV scan was taken between 200 to 400 nm. The 
absorption maximum was found to be 239 nm and was used 
for the further analytical studies. 
Calibration curve of Tamoxifen in 0.1 N HCL: 
The standard solutions were prepared by proper dilutions 
of the primary stock solution (1000 μg/ml) with buffer to 
obtain working standards in the concentration range of 5-
25µg/ml of pure sample of Tamoxifen. The concentration of 
Tamoxifen present in the microspheres was obtained from 
the calibration curve. 
Calibration curve of Tamoxifen in pH6.8 Phosphate 
buffer: 
Standard Stock solution: 100 mg of Tamoxifen was dissolved 
in small quantity of ethanol and make up to 100 ml of pH6.8 
Phosphate buffer to give a concentration of (1000 μg/ml). 
The standard solutions were prepared by proper dilutions 
of the primary stock solution with buffer to obtain working 
standards in the concentration range of 5-25µg/ml of pure 
sample of Tamoxifen. The concentration of Tamoxifen 
present in the microspheres was obtained from the 
calibration curve. 
2.2.2 Drug-Excipients Compatibility study8 
TMX was mixed with all excipients, used in the formulation 
in different ratios and subjected to FTIR. Prior to the 
development of the dosage forms the preformulation study 
was carried out. IR spectral studies lies more in the 
qualitative identification of substances either in pure form 
or in combination with polymers and excipients and acts as a 
tool in establishment of chemical interaction. Since I.R. is 
related to covalent bonds, the spectra can provide detailed 
information about the structure of molecular compounds. In 
order to establish this point, comparisons were made 
between the spectrum of the substances and the pure 
compound. The above discussions imply that infrared data is 
helpful to confirm the identity of the drug and to detect the 
interaction of the drug with the carriers. FTIR spectra were 
recorded with a Thermo Nicolet. Japan In the range 400–
4000 cm−1 using a resolution of 4 cm−1 and 16 scans. 
Samples were diluted with KBr mixing Powder, and pressed 
to obtain self-supporting disks. Liquid samples formulations 
were analyzed to form a thin liquid film between two KBr 
disks9. 
2.2.3 Preparation of double walled microspheres of 
TMX10,11 
The double walled microspheres were prepared by two step 
process. In first step the core microspheres of sodium 
Alginate and with different polymers were formulated. The 
microspheres then dispersed in the organic phase. The 
organic phase containing polymer in which drug was 
dissolved then the organic phase was emulsified with liquid 
paraffin. The solvent was allowed to evaporate and double 
walled microspheres were collected. 
Formulation of Core Microspheres with Drug: TMX and 
all other polymers were individually passed through sieve   
no60. The required quantities of Sodium alginate and the 
polymer were dissolved in purified water to form a 
homogenous polymer solution. TMX was added to the 
polymer solution and mixed thoroughly with a stirrer to 
form a viscous dispersion. The resulting dispersion was then 
added manually drop wise into calcium chloride (1.5% w/v) 
solution through a syringe with a needle of size no.22. The 
added droplets were retained in the calcium chloride 
solution for 15 minutes to complete the curing reaction and 
to produce the spherical rigid microspheres. Microspheres 
were collected by decantation, and the product thus 
separated was washed repeatedly with water and dried at 
45⁰C for12 hours.      
Formulation of Double Walled Microspheres: The 
previously formulated microspheres were dispersed in the 
organic phase. The second polymer 3%HPMC Phthalate was 
dissolved in the same organic phase. The resulting organic 
phase solution was emulsified in liquid paraffin. 1% span 80 
solutions were used as emulsifying agent. Above emulsion 
was stirred for complete evaporation of the organic solution. 
After complete evaporation of the organic solution the 
double walled microspheres were collected by vacuum 
filtration and washed with n-hexane. The resulted double 
walled microspheres were freeze dried for 24hrs.
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Table no.1: TMX Double walled Microspheres formulations 
Ingredients (%) F1 F2 F3 F4 F5 F6 F7 
Tamoxifen (mg) 100 100 100 100 100 100 100 
Sodium alginate (mg) 200 200 200 200 200 200 200 
Guar gum (mg) - 100 - - 200 - - 
Xanthun gum - - 100 - - 200 - 
HPMC - - - 100 - - 200 
Water(ml) 20 20 20 20 20 20 20 
 
Outer phase 
CaCl2 1g 
IPA 50ml 
 
2.2.4 Evaluation of Microspheres12 
Scanning electron microscopy (SEM): The morphology of 
the microspheres was studied using scanning electron 
microscopy (SEM).The samples for SEM were prepared by 
lightly sprinkling on a double adhesive tape stuck to an 
aluminum stub. The stubs were then coated with gold film 
under reduced pressure. The stub containing the coated 
samples was placed in the scanning electron microscope 
(Hitachi S3400N) chamber. The samples were then 
randomly scanned, and photomicrographs were taken at the 
acceleration voltage of 5 kV. Microphotographs were taken 
on different magnification and higher magnification was 
used for surface morphology.  
Particle size analysis: Samples of the micro particles were 
analyzed for particle size by optical microscope. The 
instrument was calibrated and found that 1unit of eyepiece 
micrometer was equal to 12.5μm. Nearly about 100 Micro 
particles sizes were calculated under 45x magnification.
 
The average particle size was determined by using the Edmo
ndson’s equation: 
            nd 
Dmean = ------ 
            n 
Where, 
n – Number of microspheres observed, d – Mean size range 
Drug Entrapment Efficiency: Microspheres equivalent to 
20mg of the drug were taken for evaluation. The amount of 
drug entrapped was estimated by crushing the 
microspheres and extracting with aliquots of pH6.8 
Phosphate buffer repeatedly. The extract was transferred to 
a 100ml volumetric flask and the volume was made up 
using pH6.8 Phosphate buffer. The solution was filtered 
and the absorbance was measured after 
suitable dilution spectrophotometrically (UV 1700, 
Shimadzu, Japan) at 239 nm against appropriate blank. 
The amount of drug loaded and entrapped in the 
microspheres was calculated by the following formulas:
  
   Drug entrapment efficiency (%) = Amount of drug actually present   × 100 
                                                               Theoretical drug load expected 
Determination of Percentage yield: The dried microspheres were weighed and percentage yield of the prepared 
Microspheres were calculated by using the following formula13. 
 Percentage yield =        Practical yield (mg) ×100 
                                                     Theoretical yield   
 
In-vitro Release Study14: The drug release study was 
performed for microsphere containing quantity 
equivalent to 20mg of TMX Microspheres by using USP 
dissolution apparatus Type I (Lab India DS 8000) in 900 
ml of 0.1  N HCL f or  f i r st  2hr s the n re place d with  
pH6.8 Phosphate buffer dissolution media at 50 rpm and 
370C temperature. 5 ml of sample was withdrawn at 
predetermined time interval for 12 hours and same volume 
of fresh medium was replaced to maintained sink condition. 
Withdrawn samples were assayed spectrophoto metrically 
at 239 nm. The cumulative percentage drug release was 
calculated using standard calibration curve. 
Release kinetics13: The release data obtained was fitted 
into various mathematical models. The parameters ‘n’, time 
constant ‘k’, the release rate constant ‘R’, the regression 
coefficient were determined by Korsmeyer-peppas equation 
to understand the release mechanism. To examine the 
release mechanism of TMX from the microspheres, the 
release data was fitted into peppa’s equation, 
Mt / M∞ = Ktn 
Where, Mt/M∞ is the fractional release of drug, ‘t’ denotes 
the release time, ‘K’ represents a constant incorporation 
structural and geometrical characteristics of the device, ‘n’ is 
the diffusional exponent and characterize the type of release 
mechanism during the release process. 
Table no.2: Diffusional exponent- type of release 
mechanism 
Release exponent 
(n) 
Drug transport 
mechanism 
0.5 Fickian diffusion 
0.5<n<1.0 
Anomalous transport or   
non-Fickian 
1.0 Case-II transport 
Higher than 1.0 Super Case-II transport 
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If n < 0.5, the polymer relaxation does not affect the 
molecular transport,  
hence diffussion is Fickian.  
If n > 0.5, the solid transport will be non-fickian and will be 
relaxation controlled. 
Other equations to study the drug release kinetics from 
dosage forms 
a. Zero order 
% R=kt 
This model represents an ideal release in order to achieve 
prolonged pharmacological action. This is applicable to 
dosage froms like transdermal systems, coated forms, 
osmotic systems, as well as Matrix tablets containing low 
soluble drugs. 
 
b. First order 
log (fraction unreleased)=kt/2.303 
The model is applicable to hydrolysis kinetics and to study 
the release profiles of pharmaceutical dosage forms such as 
those containing water soluble drugs in porous matrices. 
c. Matrix (Higuchi Matrix) 
%R=kt0.5 
This model is applicable to systems with drug dispersed in 
uniform swellable polymer matrix as in case of matrix tablets 
with water soluble drug. 
d. Peppas Korsmeyer Equation 
%R=ktn 
log %R= logk + nlogt 
This model is widely used when release mechanism is well 
known or when more than one type of release phenomenon 
could be involved. 
  
 
3. RESULTS AND DISCUSSION 
3.1 Estimation of Tamoxifen (API) 
Table no.3: Description, solubility and melting point of TMX (API) 
Description Color - A white or almost white crystalline powder 
Odor – Free of odor 
Solubility Methanol – Freely soluble 
Dichloromethane – Soluble 
Water – Slightly soluble 
Acetonitrile – Practically soluble 
Mpt 192 – 1950C 
 
3.2 Scanning:  
 
Figure no.1: UV Visible spectrum of TMX observed at 239nm 
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3.3 Calibration curve of Tamoxifen in 0.1N HCL and 6.8pH phosphate buffer: 
a  b  
Figure no.2: Linearity curve of TMX in a) 0.1N HCL b) 6.8pH phosphate buffer 
3.4 Drug and Excipients compatibility studies (FTIR): 
 
Figure no.3: FTIR spectra of TMX (API) 
 
Figure no.4: FTIR Spectra of TMX optimized formulation 
Table no.4: FTIR Interpretation Table 
Characteristic peak Observed range Pure drug  Optimized formulation 
C-H STRECH 300-2830 2833.26 2832.82 
C-N 1260-1020 1223.51 1252.88 
 
FTIR studies were performed to understand the 
compatibilities between the drugs with different excipients. 
The figures above illustrate that the functional groups like C-
H STRECH with the observation range of 300-2830 has 
peaks at 2833.26 in pure drug and 2832.82 in optimized 
formulation. Similarly the functional group C-N has a peak 
range of 1260-1020 has peaks at 1223.51 in pure drug and 
1252.88 in optimized formulation. The functional groups in 
both the pure drug and optimized formulation are found. 
Hence it can be concluded that the pure drug is compatible 
with the excipients used in the study.   
3.5 Evaluation and characterization of Microspheres:                                                        
3.5.1 Percentage Yield and Drug entrapment efficiency:  
Percentage yield was found to be in the range of 79.7 to 
86.4% for microspheres containing sodium alginate along 
with other polymers.  
Percentage Drug entrapment efficiency of TMX in different 
formulations ranged from 76.5 to 89.4% for double walled 
microspheres. Drug entrapment efficiency increases with the 
increase in proportion of the respective polymers 
concentration, particle size also increases exponentially with 
increased viscosity of dispersed phase. 
Table no.5: Percentage yield and Drug entrapment 
efficiency of TMX microspheres 
Formulation 
code 
Percentage  
yield 
%Drug entrapment 
efficiency 
F1 81.1 80.2 
F2 84.6 76.5 
F3 85.8 84.7 
F4 86.4 85.2 
F5 79.7 86.6 
F6 84.2  88.2 
F7 85.9 89.4 
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3.5.2 Particle size analysis: The mean size increased with 
increasing polymer concentration which is due to a 
significant increase in the viscosity, leads to increase in 
droplet size and finally a higher microspheres size. 
Microspheres containing least polymer concentration had 
achieved lease size range of 610 µm. 
 
Figure no.5: Average particle size of TMX microspheres
3.5.3 Scanning Electron Microscopy (SEM): 
 
Figure no.6: SEM of a,e) solid microspheres; c) surface morphology; b,d) microspheres of varying size; f) perforated 
microspheres. 
 
3.5.4 In-vitro drug release studies:  
 
Figure no.7: In-vitro drug release profile of TMX 
Microspheres 
(F1-97.74/8hrs, F2-90.64/8hrs, F3-92.62/10hrs, F4-
95.4/12hrs) 
 
Figure no.8: In-vitro drug release profile of TMX 
Microspheres 
(F5-94.51/10hrs, F6-95.84/10hrs, F7-99.1/12hrs) 
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As per the dissoultution study of formulations F1-F7, the 
maximum drug release is observed for F7 formulation at 12th 
hour, hence F7 considered as optimized formulation. 
Drug Release Kinetics: 
A  
B  
C  
D  
Figure no.9: Drug release kinetics for TMX F7 
formulation: A) Zero order, B) First order, C) Higuchi 
and D) Korsmeyer-Peppas plot 
 Based on coefficient of determination and release exponent 
values, it can be suggested that the mechanism of drug 
release follows Zero order kinetics which is independent on 
concentration and Peppas model shows Non-fickian 
diffusion mechanism. In-vitro drug release of TMX 
microspheres followed combination of diffusion and spheres 
erosion. 
4. CONCLUSION 
In present work, double walled microspheres of TMX were 
fabricated by Ion gelation method to deliver TMX via oral 
route using Sodium alginate, HPMC, Guar gum, and Xanthun 
gum polymers.  Increase in the polymer concentration lead 
to increase in percentage yield, drug entrapment efficiency 
and particle size. Optimized F7 formulation followed Zero 
order and Non-fickian diffusion mechanism.  
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